Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

AMERICAN HEALTHCARE REIT ($AHR) Releases Q4 2025 Earnings

None

AMERICAN HEALTHCARE REIT ($AHR) posted quarterly earnings results for Q4 2025 on Thursday, February 26th. The company reported earnings of $0.46 per share, beating estimates of $0.16 by $0.30. The company also reported revenue of $604,080,000, missing estimates of $614,206,684 by $-10,126,684.

Stock price change since market close: -1.5%

You can see Quiver Quantitative's $AHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

AMERICAN HEALTHCARE REIT Insider Trading Activity

AHR Insider Trades

AMERICAN HEALTHCARE REIT insiders have traded $AHR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $AHR stock by insiders over the last 6 months:

  • JEFFREY T HANSON has made 0 purchases and 3 sales selling 74,788 shares for an estimated $3,644,504.
  • MARK E. FOSTER (EVP, GC & Secretary) has made 0 purchases and 2 sales selling 5,350 shares for an estimated $235,301.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AMERICAN HEALTHCARE REIT Hedge Fund Activity

We have seen 283 institutional investors add shares of AMERICAN HEALTHCARE REIT stock to their portfolio, and 226 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMERICAN HEALTHCARE REIT Analyst Ratings

Wall Street analysts have issued reports on $AHR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Truist Securities issued a "Buy" rating on 01/20/2026
  • Morgan Stanley issued a "Overweight" rating on 11/20/2025
  • UBS issued a "Buy" rating on 11/17/2025
  • Keybanc issued a "Overweight" rating on 11/13/2025
  • Scotiabank issued a "Sector Outperform" rating on 11/13/2025
  • RBC Capital issued a "Outperform" rating on 11/12/2025
  • Citizens issued a "Market Outperform" rating on 11/10/2025

To track analyst ratings and price targets for AMERICAN HEALTHCARE REIT, check out Quiver Quantitative's $AHR forecast page.

AMERICAN HEALTHCARE REIT Price Targets

Multiple analysts have issued price targets for $AHR recently. We have seen 10 analysts offer price targets for $AHR in the last 6 months, with a median target of $55.0.

Here are some recent targets:

  • Aaron Hecht from Citizens set a target price of $60.0 on 02/05/2026
  • Juan Sanabria from BMO Capital set a target price of $55.0 on 01/29/2026
  • Michael Lewis from Truist Securities set a target price of $52.0 on 01/20/2026
  • Nick Joseph from Citigroup set a target price of $52.0 on 11/21/2025
  • Ronald Kamdem from Morgan Stanley set a target price of $55.0 on 11/20/2025
  • Michael Goldsmith from UBS set a target price of $56.0 on 11/17/2025
  • Austin Wurschmidt from Keybanc set a target price of $55.0 on 11/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles